G protein subunit G alpha 16 expression is restricted to progenitor B cells during human B-cell differentiation.

Abstract:

:Recently G alpha 16, a new guanosine triphosphate (GTP) binding protein alpha subunit has been described to be specifically expressed in human hematopoietic cells. Expression of G alpha 16 was observed in human cell lines of myelomonocytic and T-lymphocytic origin, but not in human B-cell lines Raji and IM9. We studied the expression of G alpha 16 in human B cells corresponding to different stages of B-cell differentiation by means of reverse transcriptase-polymerase chain reaction (RT-PCR) and Western blotting. The human Burkitt's lymphoma cell lines Raji, Ramos, BJAB, the lymphoblastoid cell line SKW6.4, and the plasmocytoma cell line U266 were devoid of G alpha 16. In contrast, G alpha 16 was detected in the human progenitor B cell lines Reh and Nalm-6. Using the mu+, k- cell line BLIN-1 (pre-B cell phenotype) and its derived subclone 1E8 (surface mu+, k+; B-cell phenotype) G alpha 16 expression was found to disappear on transition from pre-B to B-cell differentiation stage. The analysis of a broad panel of human neoplastic B lymphocytes ranging from progenitor B-acute lymphatic leukemia (pre-pre-B-ALL), common acute leukemias (cALL), pre-B-ALL, mature B-ALL to low grade B-cell lymphoma (chronic lymphocytic leukemia of B-cell type, leukemic centrocytic non-Hodgkins lymphoma [NHL], hairy cell leukemia) showed that G alpha 16 expression is limited to progenitor and pre-B-ALL cells. Therefore, we conclude that within B-cell differentiation, G alpha 16 is expressed solely during early B cell ontogeny and downregulated during differentiation. Thus, G alpha 16 might be an important regulator involved in signaling processes in progenitor B cells.

journal_name

Blood

journal_title

Blood

authors

Mapara MY,Bommert K,Bargou RC,Leng C,Beck C,Ludwig WD,Gierschik P,Dörken B

subject

Has Abstract

pub_date

1995-04-01 00:00:00

pages

1836-42

issue

7

eissn

0006-4971

issn

1528-0020

journal_volume

85

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Prognostic significance of baseline metabolic tumor volume in relapsed and refractory Hodgkin lymphoma.

    abstract::Identification of prognostic factors for patients with relapsed/refractory Hodgkin lymphoma (HL) is essential for optimizing therapy with risk-adapted approaches. In our phase 2 study of positron emission tomography (PET)-adapted salvage therapy with brentuximab vedotin (BV) and augmented ifosfamide, carboplatin, and ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2017-06-788877

    authors: Moskowitz AJ,Schöder H,Gavane S,Thoren KL,Fleisher M,Yahalom J,McCall SJ,Cadzin BR,Fox SY,Gerecitano J,Grewal R,Hamlin PA,Horwitz SM,Kumar A,Matasar M,Ni A,Noy A,Palomba ML,Perales MA,Portlock CS,Sauter C,Straus

    更新日期:2017-11-16 00:00:00

  • Caspases mediate tumor necrosis factor-alpha-induced neutrophil apoptosis and downregulation of reactive oxygen production.

    abstract::Tumor necrosis factor-alpha (TNF-alpha) exerts two separate effects on neutrophils, stimulating effector functions while simultaneously inducing apoptosis. We examined here the involvement of caspases in neutrophil apoptosis and the effect of TNF-alpha-induced apoptosis on reactive oxygen production. Immunoblotting an...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Yamashita K,Takahashi A,Kobayashi S,Hirata H,Mesner PW Jr,Kaufmann SH,Yonehara S,Yamamoto K,Uchiyama T,Sasada M

    更新日期:1999-01-15 00:00:00

  • Promoter SNPs in G1/S checkpoint regulators and their impact on the susceptibility to childhood leukemia.

    abstract::Mutations leading to the alteration of cell-cycle checkpoint functions are a common feature of most cancers. Because of the highly regulated nature of the cell cycle, it seems likely that variation in gene dosage of key components due to functional regulatory polymorphisms could play an important role in cancer develo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-02-003236

    authors: Healy J,Bélanger H,Beaulieu P,Larivière M,Labuda D,Sinnett D

    更新日期:2007-01-15 00:00:00

  • The T-cell CD2 determinant mediates inhibition of erythropoiesis by the lymphokine cascade.

    abstract::We examined the role of the T-cell antigen CD2 in the regulation of erythropoiesis by the lymphokine cascade. T-cell interleukin-2 (IL-2) receptors (p55) were induced via triggering of the antigen receptor-associated CD3 epitope. Before CD3 triggering T cells were preincubated with a CD2-blocking (Leu-5b) or isotype c...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Burdach S,Shatsky M,Wagenhorst B,Levitt L

    更新日期:1988-08-01 00:00:00

  • Bif-1 haploinsufficiency promotes chromosomal instability and accelerates Myc-driven lymphomagenesis via suppression of mitophagy.

    abstract::Malignant transformation by oncogenes requires additional genetic/epigenetic changes to overcome enhanced susceptibility to apoptosis. In the present study, we report that Bif-1 (Sh3glb1), a gene encoding a membrane curvature–driving endophilin protein, is a haploinsufficient tumor suppressor that plays a key role in ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-10-459826

    authors: Takahashi Y,Hori T,Cooper TK,Liao J,Desai N,Serfass JM,Young MM,Park S,Izu Y,Wang HG

    更新日期:2013-02-28 00:00:00

  • Vascular cell adhesion molecule 1 (VCAM-1) activation of endothelial cell matrix metalloproteinases: role of reactive oxygen species.

    abstract::Lymphocytes bound at endothelial cell junctions extravasate within minutes. Lymphocyte-endothelial cell binding is mediated by receptors such as vascular cell adhesion molecule 1 (VCAM-1). VCAM-1 activates endothelial cell nicotinamide adenine dinucleotide phosphate (NADPH) oxidase in minutes, and this activity is req...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-02-0665

    authors: Deem TL,Cook-Mills JM

    更新日期:2004-10-15 00:00:00

  • Antithrombin Milano: a new variant with monomeric and dimeric inactive antithrombin III.

    abstract::A qualitative defect of antithrombin III (AT III) has been demonstrated over three generations in eight members of an Italian family by the discrepancy between a normal amount of antigen and decreased antithrombin and anti-Xa activity in the presence or in the absence of heparin. By two-dimensional immunoelectrophores...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Wolf M,Boyer C,Tripodi A,Meyer D,Larrieu MJ,Mannucci PM

    更新日期:1985-02-01 00:00:00

  • Large granular lymphocyte proliferation: an analysis of T-cell receptor gene arrangement and expression and the effect of in vitro culture with inducing agents.

    abstract::The status of the T cell receptor beta and gamma genes in natural killer (NK) cells was investigated in two patients with a marked expansion of CD2+, CD3- NK cells. Both genes were found to be in the germline state. The T alpha and complete T beta gene transcripts were not detected, but a 1.0-kilobase T beta gene tran...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Chan WC,Dahl C,Waldmann T,Link S,Mawle A,Nicholson J,Bach FH,Bongiovanni K,McCue PA,Winton EF

    更新日期:1988-01-01 00:00:00

  • Regulation of CCR6 chemokine receptor expression and responsiveness to macrophage inflammatory protein-3alpha/CCL20 in human B cells.

    abstract::The regulation of CCR6 (chemokine receptor 6) expression during B-cell ontogeny and antigen-driven B-cell differentiation was analyzed. None of the CD34(+)Lin(-) hematopoietic stem cell progenitors or the CD34(+)CD19(+) (pro-B) or the CD19(+)CD10(+) (pre-B/immature B cells) B-cell progenitors expressed CCR6. CCR6 is a...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Krzysiek R,Lefevre EA,Bernard J,Foussat A,Galanaud P,Louache F,Richard Y

    更新日期:2000-10-01 00:00:00

  • Macrophage colony-stimulating factor and granulocyte-macrophage colony-stimulating factor stimulate the synthesis of plasminogen-activator inhibitors by human monocytes.

    abstract::Macrophage colony-stimulating factor (M-CSF or CSF-1) and granulocyte-macrophage CSF (GM-CSF) have been shown to increase human monocyte urokinase-type plasminogen-activator (u-PA) activity with possible consequences for cell migration and tissue remodeling; because monocyte u-PA activity is likely to be controlled in...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Hamilton JA,Whitty GA,Stanton H,Wojta J,Gallichio M,McGrath K,Ianches G

    更新日期:1993-12-15 00:00:00

  • Prevalence of 25-hydroxyvitamin D deficiency in subgroups of elderly persons with anemia: association with anemia of inflammation.

    abstract::Anemia and vitamin D deficiency are conditions that both result in significant morbidity and increase with age. The potential relationship between them remains poorly understood, particularly in the elderly. We used the Third National Health and Nutrition Examination Survey to examine the association of vitamin D defi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-09-309708

    authors: Perlstein TS,Pande R,Berliner N,Vanasse GJ

    更新日期:2011-03-10 00:00:00

  • Depletion of the C3 component of complement enhances the ability of rituximab-coated target cells to activate human NK cells and improves the efficacy of monoclonal antibody therapy in an in vivo model.

    abstract::Growing evidence indicates antibody-dependent cellular cytotoxicity (ADCC) contributes to the clinical response to monoclonal antibody (mAb) therapy of lymphoma. Recent in vitro analysis suggests C3b can inhibit mAb-induced natural killer (NK)-cell activation and ADCC. Further studies were conducted to assess the effe...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-01-200469

    authors: Wang SY,Veeramani S,Racila E,Cagley J,Fritzinger DC,Vogel CW,St John W,Weiner GJ

    更新日期:2009-12-17 00:00:00

  • 2',5'-Oligoadenylate-antisense chimeras cause RNase L to selectively degrade bcr/abl mRNA in chronic myelogenous leukemia cells.

    abstract::We report an RNA targeting strategy, which selectively degrades bcr/abl mRNA in chronic myelogenous leukemia (CML) cells. A 2', 5'-tetraadenylate activator (2-5A) of RNase L was chemically linked to oligonucleotide antisense directed against either the fusion site or against the translation start sequence in bcr/abl m...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Maran A,Waller CF,Paranjape JM,Li G,Xiao W,Zhang K,Kalaycio ME,Maitra RK,Lichtin AE,Brugger W,Torrence PF,Silverman RH

    更新日期:1998-12-01 00:00:00

  • Subtractive hybridization reveals the expression of immunoglobulin-like transcript 7, Eph-B1, granzyme B, and 3 novel transcripts in human plasmacytoid dendritic cells.

    abstract::Recent studies in humans have highlighted the importance of a distinct cellular entity, the plasmacytoid dendritic cell (PDC). To identify genes for which expression is restricted to human PDCs, a cDNA subtraction technique was applied using cDNA from activated monocyte-derived DCs (MDDCs) as competitor. In the 650 se...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-02-0638

    authors: Rissoan MC,Duhen T,Bridon JM,Bendriss-Vermare N,Péronne C,de Saint Vis B,Brière F,Bates EE

    更新日期:2002-11-01 00:00:00

  • Dysregulation of granulocyte, erythrocyte, and NK cell lineages in Fli-1 gene-targeted mice.

    abstract::Targeted disruption of the Friend leukemia integration 1 (Fli-1) proto-oncogene results in severe dysmegakaryopoiesis and embryonic lethality. We used morula-stage aggregation as a strategy to further clarify the hematopoietic defects of the Fli-1 gene-targeted mice. Analyses of lineage expression of Fli-1(+/-) and Fl...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-12-4345

    authors: Masuya M,Moussa O,Abe T,Deguchi T,Higuchi T,Ebihara Y,Spyropoulos DD,Watson DK,Ogawa M

    更新日期:2005-01-01 00:00:00

  • Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects.

    abstract::The effects of colony-stimulating factor 1 (CSF-1), the primary regulator of mononuclear phagocyte production, are thought to be mediated by the CSF-1 receptor (CSF-1R), encoded by the c-fms proto-oncogene. To investigate the in vivo specificity of CSF-1 for the CSF-1R, the mouse Csf1r gene was inactivated. The phenot...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.1.111

    authors: Dai XM,Ryan GR,Hapel AJ,Dominguez MG,Russell RG,Kapp S,Sylvestre V,Stanley ER

    更新日期:2002-01-01 00:00:00

  • Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?

    abstract::Improved supportive care, more precise risk stratification, and personalized chemotherapy based on the characteristics of leukemic cells and hosts (eg, pharmacokinetics and pharmacogenetics) have pushed the cure rate of childhood acute lymphoblastic leukemia to near 90%. Further increase in cure rate can be expected f...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2012-05-378943

    authors: Pui CH,Mullighan CG,Evans WE,Relling MV

    更新日期:2012-08-09 00:00:00

  • Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin.

    abstract::Ferroportin (FPN) mediates iron export from cells; FPN mutations are associated with the iron overloading disorder hemochromatosis. Previously, we found that the A77D, V162del, and G490D mutations inhibited FPN activity, but that other disease-associated FPN variants retained full iron export capability. The peptide h...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-02-0561

    authors: Drakesmith H,Schimanski LM,Ormerod E,Merryweather-Clarke AT,Viprakasit V,Edwards JP,Sweetland E,Bastin JM,Cowley D,Chinthammitr Y,Robson KJ,Townsend AR

    更新日期:2005-08-01 00:00:00

  • Contribution of natural killer cells to inhibition of angiogenesis by interleukin-12.

    abstract::Interleukin-12 (IL-12) inhibits angiogenesis in vivo by inducing interferon-gamma (IFN-gamma) and other downstream mediators. Here, we report that neutralization of natural killer (NK) cell function with antibodies to either asialo GM1 or NK 1.1 reversed IL-12 inhibition of basic fibroblast growth factor (bFGF)-induce...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Yao L,Sgadari C,Furuke K,Bloom ET,Teruya-Feldstein J,Tosato G

    更新日期:1999-03-01 00:00:00

  • Neutral tumor evolution in myeloma is associated with poor prognosis.

    abstract::Recent studies suggest that the evolutionary history of a cancer is important in forecasting clinical outlook. To gain insight into the clonal dynamics of multiple myeloma (MM) and its possible influence on patient outcomes, we analyzed whole exome sequencing tumor data for 333 patients from Myeloma XI, a UK phase 3 t...

    journal_title:Blood

    pub_type: 杂志文章,随机对照试验

    doi:10.1182/blood-2016-11-750612

    authors: Johnson DC,Lenive O,Mitchell J,Jackson G,Owen R,Drayson M,Cook G,Jones JR,Pawlyn C,Davies FE,Walker BA,Wardell C,Gregory WM,Cairns D,Morgan GJ,Houlston RS,Kaiser MF

    更新日期:2017-10-05 00:00:00

  • IL10RA modulates crizotinib sensitivity in NPM1-ALK+ anaplastic large cell lymphoma.

    abstract::Anaplastic large cell lymphoma (ALCL) is a T-cell malignancy predominantly driven by a hyperactive anaplastic lymphoma kinase (ALK) fusion protein. ALK inhibitors, such as crizotinib, provide alternatives to standard chemotherapy with reduced toxicity and side effects. Children with lymphomas driven by nucleophosmin 1...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019003793

    authors: Prokoph N,Probst NA,Lee LC,Monahan JM,Matthews JD,Liang HC,Bahnsen K,Montes-Mojarro IA,Karaca-Atabay E,Sharma GG,Malik V,Larose H,Forde SD,Ducray SP,Lobello C,Wang Q,Luan SL,Pospíšilová Š,Gambacorti-Passerini C,Burk

    更新日期:2020-10-01 00:00:00

  • Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome.

    abstract::Autoimmune lymphoproliferative syndrome (ALPS) is characterized by childhood onset of lymphadenopathy, hepatosplenomegaly, autoimmune cytopenias, elevated numbers of double-negative T (DNT) cells, and increased risk of lymphoma. Most cases of ALPS are associated with germline mutations of the FAS gene (type Ia), where...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-01-263145

    authors: Dowdell KC,Niemela JE,Price S,Davis J,Hornung RL,Oliveira JB,Puck JM,Jaffe ES,Pittaluga S,Cohen JI,Fleisher TA,Rao VK

    更新日期:2010-06-24 00:00:00

  • Spatial localization of transplanted hemopoietic stem cells: inferences for the localization of stem cell niches.

    abstract::The spatial distribution of subpopulations of hemopoietic progenitor cells following syngeneic transplantation was investigated at the single-cell level. The location of infused hemopoietic progenitor cells within the femoral bone marrow of nonablated recipients was determined by 5-(and-6)-carboxyfluorescein diacetate...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v97.8.2293

    authors: Nilsson SK,Johnston HM,Coverdale JA

    更新日期:2001-04-15 00:00:00

  • Biomarkers for prediction of venous thromboembolism in cancer.

    abstract::Cancer patients are at increased risk of deep vein thrombosis and pulmonary embolism. The incidence among different groups of cancer patients varies considerably depending on clinical factors, the most important being tumor entity and stage. Biomarkers have been specifically investigated for their capacity of predicti...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2013-04-460147

    authors: Pabinger I,Thaler J,Ay C

    更新日期:2013-09-19 00:00:00

  • Contribution of clonal hematopoiesis to adult-onset hemophagocytic lymphohistiocytosis.

    abstract::Adult-onset hemophagocytic lymphohistiocytosis (HLH) is a rare, life-threatening disease of immune hyperactivation. Unlike pediatric HLH, adult HLH is rarely driven by germline genetic variants. Although numerous precipitating etiologies have been identified, the reason that HLH occurs in only a subset of individuals ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2020008206

    authors: Miller PG,Sperling AS,Gibson CJ,Viswanathan K,Castellano C,McConkey M,Ceremsak J,Taylor MS,Birndt S,Perner F,Arnason J,Agrawal M,Schram AM,Nikiforow S,Pihan G,Hasserjian RP,Aster JC,La Rosée P,Morgan EA,Berliner N,

    更新日期:2020-12-24 00:00:00

  • Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy.

    abstract::Transplantation-associated thrombotic microangiopathy (TA-TMA) is a challenging diagnosis after hematopoietic stem cell transplantation. Although endothelial injury represents the final common pathway of disease, the exact pathophysiology of TA-TMA remains unclear. Potential causes include infections, chemotherapy, ra...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2011-02-321315

    authors: Laskin BL,Goebel J,Davies SM,Jodele S

    更新日期:2011-08-11 00:00:00

  • Acute hyperviscosity: syndromes and management.

    abstract::Plasma hyperviscosity is a rare complication of both monoclonal and polyclonal disorders associated with elevation of immunoglobulins. Asymptomatic patients with an elevation in the serum viscosity do not require plasma exchange, and the majority will have other indications for therapeutic intervention. For patients w...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2018-06-846816

    authors: Gertz MA

    更新日期:2018-09-27 00:00:00

  • Use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous marrow transplantation for lymphoid malignancies.

    abstract::The use of recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) following autologous marrow transplantation for lymphoid malignancies was explored in a phase I/II dose escalation study. rhGM-CSF given as a 2-hour infusion daily for 14 days was well tolerated at doses up to 240 micrograms/m2/da...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Nemunaitis J,Singer JW,Buckner CD,Hill R,Storb R,Thomas ED,Appelbaum FR

    更新日期:1988-08-01 00:00:00

  • The novel subset of CD14+/CD16+ blood monocytes is expanded in sepsis patients.

    abstract::Staining with CD14 and CD16 monoclonal antibodies will identify two monocyte subpopulations in human blood: a major population of regular monocytes, which strongly expresses the CD14 antigen (CD14++), and a minor population with weak expression of CD14 and expression of the CD16 antigen (CD14+/CD16+ cells). As shown h...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Fingerle G,Pforte A,Passlick B,Blumenstein M,Ströbel M,Ziegler-Heitbrock HW

    更新日期:1993-11-15 00:00:00

  • Bryostatin 1, a unique biologic response modifier: anti-leukemic activity in vitro.

    abstract::Bryostatin 1, a macrocyclic lactone isolated from the marine bryozoan Bugula neritina, has demonstrated both antineoplastic activity against the murine P388 leukemia line in vivo and stimulatory activity against mouse and human hematopoietic progenitors. We studied the effects of bryostatin 1 on the growth of human le...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Jones RJ,Sharkis SJ,Miller CB,Rowinsky EK,Burke PJ,May WS

    更新日期:1990-03-15 00:00:00